Tag Archives: Alzheimer’s disease

Biotech Researchers Eye Alzheimer’s Breakthroughs
Years after President Reagan’s Courageous “Sunset”

new-bio-logo

Like most Americans, I have enormous admiration for President Ronald Reagan. The world witnessed his courage and conviction when he confronted communism at the Brandenburg Gate. I also admire the 40th President for the bravery he showed after leaving office when he publicly shared his Alzheimer’s diagnosis. In so doing, he transformed the global Alzheimer’s conversation from a whisper to a roar. One of our greatest leaders helped tear down walls and tear down the Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , ,

ICYMI: Potential New Drug for Alzheimer’s Shows Promise in Early Trial

health care, medicine

Last week, the Washington Post published an article titled Alzheimer’s Drug Trial Sparks Optimism which highlighted new findings from a paper published in Nature. They shared exciting news of positive early trial results for a potential new Alzheimer’s treatment. “Overall this is the best news that we’ve had in my 25 years doing Alzheimer’s clinical research and it brings new hope for patients and families most affected by the disease,” said one of the study’s Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

8 Reasons New Medicines are Needed for Alzheimer’s

synthetic biology

Last week, the Alzheimer’s Association released an infographic with eight mythbusting facts to help dispel common misconceptions about the disease when it comes to prevention, financial impact, symptoms, and other areas. As the infographic confirms, there is no cure for this irreversible neurological disease, and only half of people living with Alzheimer’s (the 6th leading cause of death in the US) have actually been diagnosed. PhRMA’s report on Medicines in Development for Alzheimer’s Disease notes Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Coalition Offers a Remedy for Stagnated Clinical Trials

lab_tech

Promising new clinical trial data offers fresh hope for the families of Alzheimer’s patients.  A new medication seems to be slowing the disease’s progress, limiting the cognitive decline that characterizes this “long goodbye.” Wouldn’t it be wonderful for patients suffering other diseases to have equally encouraging prospects? But many do not. Part of the problem lies with clinical trials.  For a new medication to receive FDA approval, it must undergo comprehensive testing on actual patients.  Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

CNN: Sandy’s Story

scientist, lab

CNN launched a new series profiling Sandy Halperin, a dentist and Harvard assistant professor, to raise awareness for the devastating impact of Alzheimer’s disease on a patient and his family. Producer Stephanie Smith describes Sandy’s Story as ‘an unprecedented look at the cruel journey of a vibrant, once healthy man as he gradually loses his memory.’ Halperin was diagnosed with early stage Alzheimer’s disease at age 60. The in-depth package explores the day-to-day reality of Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,